Report Summarizes Carcinomas Study Findings from Huazhong University of Science and Technology [Sintilimab Combined With Bevacizumab In Relapsed or Persistent Ovarian Clear Cell Carcinoma (Inova): a Multicentre, Single-arm, Phase 2 Trial]

Media coverage

• Title	Report Summarizes Carcinomas Study Findings from Huazhong University of Science and Technology [Sintilimab Combined With Bevacizumab In Relapsed or Persistent Ovarian Clear Cell Carcinoma (Inova): a Multicentre, Single-arm, Phase 2 Trial]
  Media name/outlet	NewsRx Women's Health Daily
  Country/Territory	United States
  Date	10/31/24
  Persons	Zhen Li